Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108-2718, USA.
J Microencapsul. 2011;28(1):10-20. doi: 10.3109/02652048.2010.520093. Epub 2010 Oct 12.
The objective of this study was to develop and characterize a nanoparticulate-based sustained release formulation of a water soluble dipeptide prodrug of dexamethasone, valine-valine-dexamethasone (VVD). Being hydrophilic in nature, it readily leaches out in the external aqueous medium and hence partitions poorly into the polymeric matrix resulting in minimal entrapment in nanoparticles. Hence, hydrophobic ion pairing (HIP) complexation of the prodrug was employed with dextran sulphate as a complexing polymer. A novel, solid in oil in water emulsion method was employed to encapsulate the prodrug in HIP complex form in poly(lactic-co-glycolic acid) matrix. Nanoparticles were characterized with respect to size, zeta potential, crystallinity of entrapped drug and surface morphology. A significant enhancement in the entrapment of the prodrug in nanoparticles was achieved. Finally, a simple yet novel method was developed which can also be applicable to encapsulate other charged hydrophilic molecules, such as peptides and proteins.
本研究的目的是开发和表征一种基于纳米颗粒的水可溶性二肽前体药物地塞米松的缓释制剂,即缬氨酸-缬氨酸-地塞米松(VVD)。由于其亲水性,它很容易在外部水介质中浸出,因此在聚合物基质中分配不佳,导致纳米颗粒中最小的包封率。因此,采用疏水离子对(HIP)络合的前体药物与硫酸葡聚糖作为络合聚合物。采用新颖的油包水固-固乳液方法,将前体药物以 HIP 络合物的形式包封在聚(乳酸-共-羟基乙酸)基质中。对纳米颗粒的粒径、Zeta 电位、包封药物的结晶度和表面形态进行了表征。前体药物在纳米颗粒中的包封率显著提高。最后,开发了一种简单而新颖的方法,也可适用于包封其他带电亲水分子,如肽和蛋白质。